This study demonstrates the antimetastatic activity of warfarin via Cbl‐b and TAM tyrosine kinase receptors in NK cells, revealing that targeting Cbl‐b by genetic or pharmacologic approaches may be a valuable strategy for awakening the innate immune system to kill cancer metastases 115. This evidence concerns the gene CBLB and cancer.